COSM vs. ANRO
COSM (Cosmos Health Inc.) and ANRO (Alto Neuroscience, Inc) are both stocks. Both are in the Healthcare sector — COSM in Medical Distribution, ANRO in Biotechnology. Over the past year, COSM returned -51.08% vs 919.11% for ANRO. At a 0.15 correlation, their price movements are largely independent.
Performance
COSM vs. ANRO - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, COSM achieves a -57.59% return, which is significantly lower than ANRO's 28.82% return.
COSM
- 1D
- -0.80%
- 1M
- -16.36%
- YTD
- -57.59%
- 6M
- -60.15%
- 1Y
- -51.08%
- 3Y*
- -59.71%
- 5Y*
- -46.89%
- 10Y*
- -9.13%
ANRO
- 1D
- 0.84%
- 1M
- 8.06%
- YTD
- 28.82%
- 6M
- 14.42%
- 1Y
- 919.11%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
COSM vs. ANRO - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | |
|---|---|---|---|
COSM Cosmos Health Inc. | -57.59% | -25.56% | -38.06% |
ANRO Alto Neuroscience, Inc | 28.82% | 320.80% | -80.77% |
Correlation
The correlation between COSM and ANRO is 0.08, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.08 |
Correlation (All Time) Calculated using the full available price history since Feb 2, 2024 | 0.15 |
Fundamentals
COSM:
-$0.62
ANRO:
-$2.50
COSM:
$59.79M
ANRO:
$0.00
COSM:
$6.82M
ANRO:
-$421.00K
COSM:
-$14.92M
ANRO:
-$74.36M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
COSM vs. ANRO — Risk / Return Rank
COSM
ANRO
COSM vs. ANRO - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Cosmos Health Inc. (COSM) and Alto Neuroscience, Inc (ANRO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| COSM | ANRO | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -7.73 | ||
| Sortino ratioReturn per unit of downside risk | -5.97 | ||
| Omega ratioGain probability vs. loss probability | 0.96 | 1.72 | -0.75 |
| Calmar ratioReturn relative to maximum drawdown | -0.61 | 27.15 | -27.77 |
| Martin ratioReturn relative to average drawdown | -0.94 | 70.91 | -71.85 |
Loading charts...
Drawdowns
COSM vs. ANRO - Drawdown Comparison
The maximum COSM drawdown since its inception was -99.42%, which is greater than ANRO's maximum drawdown of -91.82%. Use the drawdown chart below to compare losses from any high point for COSM and ANRO.
Loading charts...
Drawdown Indicators
| COSM | ANRO | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.42% | -91.82% | -7.60% |
Max Drawdown (1Y)Largest decline over 1 year | -83.52% | -34.20% | -49.32% |
Max Drawdown (3Y)Largest decline over 3 years | -93.85% | — | — |
Max Drawdown (5Y)Largest decline over 5 years | -99.10% | — | — |
Max Drawdown (10Y)Largest decline over 10 years | -99.42% | — | — |
Current DrawdownCurrent decline from peak | -99.08% | -17.28% | -81.80% |
Average DrawdownAverage peak-to-trough decline | -63.17% | -53.30% | -9.87% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 54.54% | 13.07% | +41.47% |
Volatility
COSM vs. ANRO - Volatility Comparison
Cosmos Health Inc. (COSM) has a higher volatility of 30.00% compared to Alto Neuroscience, Inc (ANRO) at 24.19%. This indicates that COSM's price experiences larger fluctuations and is considered to be riskier than ANRO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| COSM | ANRO | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 30.00% | 24.19% | +5.81% |
Volatility (6M)Calculated over the trailing 6-month period | 57.67% | 54.92% | +2.75% |
Volatility (1Y)Calculated over the trailing 1-year period | 102.26% | 128.77% | -26.51% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 3,084.02% | 115.37% | +2,968.65% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 2,218.48% | 115.37% | +2,103.11% |
Dividends
COSM vs. ANRO - Dividend Comparison
Neither COSM nor ANRO has paid dividends to shareholders.
Financials
COSM vs. ANRO - Financials Comparison
This section allows you to compare key financial metrics between Cosmos Health Inc. and Alto Neuroscience, Inc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
COSM and ANRO have a correlation of 0.08, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
COSM has higher volatility (30.00%) compared to ANRO (24.19%). In terms of maximum drawdown, COSM dropped -99.42% vs ANRO's -91.82%.
ANRO currently has the higher Sharpe Ratio (7.23 vs -0.50), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for COSM and ANRO
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer